BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...
16:00 EST Vincerx Pharma (VINC) Inc trading halted, news pending See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investmen ...
JMP Securities analyst Jason Butler reiterated a Hold rating on Athira Pharma (ATHA – Research Report) today. The company’s shares closed yesterday at $0.42. See what stocks are receiving ...
2025 Net Product Sales Guidance: $420 million to $435 million. Mirum Pharmaceuticals Inc (NASDAQ:MIRM) reported total net product sales of $336.4 million for 2024, exceeding the upper end of their ...
Car Deal of the Day: Superb Volvo V60 returns with a lease deal that's hard to resist Car Deal of the Day: Superb Volvo V60 returns with a lease deal that's hard to resist Volvo has brought its ...
Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals' Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.
The packets were stamped with the distinctive logo of Aveo Pharmaceuticals. It's not just in Tamale that Aveo's pills are causing misery. The BBC found similar products, made by Aveo, have been ...
Is it the smoothness of running shoes or the convenience of your favourite gym shorts? Or maybe those famous logos let you know at a glance which brand you’re dealing with. In athletic apparel, logos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results